SPARK Neuro REMIND Study

Description

The study utilizes investigational software, the SPARK Test, with an FDA-cleared electroencephalography (EEG) amplifier and EEG cap to collect and then analyze patient EEG data.

Conditions

Alzheimer Disease, Cognitive Impairment

Study Overview

Study Details

Study overview

The study utilizes investigational software, the SPARK Test, with an FDA-cleared electroencephalography (EEG) amplifier and EEG cap to collect and then analyze patient EEG data.

SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and AD Status 'REMIND' Study

SPARK Neuro REMIND Study

Condition
Alzheimer Disease
Intervention / Treatment

-

Contacts and Locations

Tempe

Voyage Medical, Tempe, Arizona, United States, 85282

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Age 55 to 85 at the time of consent
  • 2. Informant available and willing (remotely or in-person) to provide information about sleep patterns and cognitive functioning who spends \>8 hours per week with primary subject
  • 3. Subject or Legally Authorized Representative (LAR) has the ability to provide informed consent and comply with the protocol.
  • 1. Unable to remain still for up to 30 minutes during EEG data recording
  • 2. Subjects currently on and unable to wash out concomitant medications, including: 1) opiates; 2) benzodiazepines and nonbenzodiazepine hypnotics; 3) sedative antihistamines; 4) tricyclic anti-depressants; 5) skeletal muscle relaxants; 6) antiepileptics; 7) antipsychotics; 8) antimanic agents; 9) THC; 10) anticholinergics
  • 3. Previous history of stroke, severe head injury, craniotomy or any other potentially confounding neurologic illness causing known structural brain damage
  • 4. Medical or psychiatric illness that would interfere with study participation
  • 5. History of epilepsy or chronic seizure disorder
  • 6. Presence of non-dental metal in head
  • 7. Currently experiencing a skin disease on scalp that would affect electrode contacts
  • 8. TICS score indicative of cognitive impairment at screening
  • 9. Substance Use Disorder, including Alcohol

Ages Eligible for Study

55 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Spark Neuro Inc.,

Study Record Dates

2025-11